Overview
Arika Hasegawa practices practicing medicine in Nishi, Japan.
Ms. Hasegawa is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Spinocerebellar Ataxia Type 31, Cytochrome C Oxidase Deficiency, Transthyretin Amyloidosis, and Spinocerebellar Ataxia Type 4.
She is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Arika Hasegawa
Is Arika Hasegawa a top-rated expert for Spinocerebellar Ataxia Type 31?
MediFind is an objective health platform that identifies experts based on real-world data. Arika Hasegawa is classified as an Advanced expert for Spinocerebellar Ataxia Type 31, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Arika Hasegawa participate in research or clinical trials?
Yes. Arika Hasegawa has published 9 articles and abstracts on conditions like Spinocerebellar Ataxia Type 31. You can view a list of Arika Hasegawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Spinocerebellar Ataxia Type 31Ms. Hasegawa isAdvanced. Learn about Spinocerebellar Ataxia Type 31.
- Experienced
- Cardiac AmyloidosisMs. Hasegawa isExperienced. Learn about Cardiac Amyloidosis.
- Cytochrome C Oxidase DeficiencyMs. Hasegawa isExperienced. Learn about Cytochrome C Oxidase Deficiency.
- Familial Transthyretin AmyloidosisMs. Hasegawa isExperienced. Learn about Familial Transthyretin Amyloidosis.
- HyperventilationMs. Hasegawa isExperienced. Learn about Hyperventilation.
- Leigh SyndromeMs. Hasegawa isExperienced. Learn about Leigh Syndrome.
- Olivopontocerebellar AtrophyMs. Hasegawa isExperienced. Learn about Olivopontocerebellar Atrophy.
- ParaplegiaMs. Hasegawa isExperienced. Learn about Paraplegia.
- Primary AmyloidosisMs. Hasegawa isExperienced. Learn about Primary Amyloidosis.
- Spastic Paraplegia Type 2Ms. Hasegawa isExperienced. Learn about Spastic Paraplegia Type 2.
- Spinocerebellar AtaxiaMs. Hasegawa isExperienced. Learn about Spinocerebellar Ataxia.
- Spinocerebellar Ataxia Type 4Ms. Hasegawa isExperienced. Learn about Spinocerebellar Ataxia Type 4.
- Spinocerebellar Ataxia Type 5Ms. Hasegawa isExperienced. Learn about Spinocerebellar Ataxia Type 5.
- Transthyretin AmyloidosisMs. Hasegawa isExperienced. Learn about Transthyretin Amyloidosis.